Olimel N9e (Valine, Alanine, Arginine, Histidine, Isoleucine, Leucine, Methionine, Phenylalanine, Proline, Serin)

Olimel N9e provides amino acid supplementation that supports several metabolic and clinical conditions.

• Protein‑energy malnutrition: helps restore nitrogen balance and lean body mass.
• Post‑surgical recovery: aids tissue repair and wound healing.
• Chronic kidney disease (conservative management): supplies essential amino acids while limiting nitrogen load.
• Inherited metabolic disorders (e.g., phenylketonuria): provides tailored amino acid composition to reduce harmful metabolites.
• Critical illness and intensive care: contributes to overall nutritional support.

• The amino acid blend in Olimel N9e supplies the body with essential building blocks for protein synthesis, stimulates the mTOR signaling pathway, and supports nitrogen balance. By providing substrates for gluconeogenesis and neurotransmitter production, it assists cellular metabolism and tissue repair without directly interacting with specific receptors.

Amino acid mixtures are generally well tolerated, but adverse reactions can occur.

Common Side Effects

• Nausea: mild to moderate gastrointestinal discomfort.
• Abdominal discomfort: bloating or cramping.
• Diarrhea: loose stools, especially with rapid dose escalation.
• Metallic taste: transient alteration in taste perception.
• Headache: mild, often resolves with continued use.

Serious or Rare Side Effects

• Hyperammonemia: elevated blood ammonia levels, requiring monitoring.
• Allergic reaction: rash, pruritus, or urticaria.
• Metabolic acidosis: rare disturbance in acid‑base balance.
• Renal impairment worsening: potential accumulation of nitrogenous waste.
• Anaphylaxis: immediate hypersensitivity requiring emergency care.

When prescribing Olimel N9e, clinicians should consider several safety aspects.

• Renal function assessment: evaluate baseline kidney performance before initiating therapy.
• Hepatic function monitoring: check liver enzymes as amino acid metabolism occurs in the liver.
• Electrolyte balance: monitor serum electrolytes, especially potassium and phosphate.
• Gradual titration: increase dose slowly to minimise gastrointestinal upset.
• Concomitant nutrition: coordinate with overall dietary plan to avoid excess protein intake.
• Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Amino acid formulations can influence the pharmacokinetics of certain medicines.

Major Interactions (Avoid)

• Levodopa: may reduce absorption of levodopa, diminishing its efficacy in Parkinson's disease.
• Thyroid hormone replacement: can interfere with absorption of levothyroxine.

Moderate Interactions (Monitor Closely)

• Anticonvulsants (e.g., valproate): may alter plasma amino acid levels.\n- Antibiotics (e.g., tetracycline): chelation may reduce antibiotic absorption.
• Iron supplements: competition for intestinal transporters can lower iron uptake.
• Diuretics: increased urinary loss of amino acids may require dose adjustment.